Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Human Research

This article was originally published in SRA

Executive Summary

US simplifies process for assuring compliance with HHS regulations

US simplifies process for assuring compliance with HHS regulations

Institutions conducting research involving human subjects supported by any agency of the US Department of Health and Human Services (HHS) now have the option of using a single, web-based ‘Federalwide Assurance’ (FWA) of compliance with HHS regulations rather than operating their own assurance systems. The new arrangement was announced by the HHS on 9 February 20051, and will be phased in by the end of the year.

Most federal agencies that support human subject research adhere to the Federal Policy for the Protection of Human Subjects, known informally as the ‘Common Rule', which requires that such research be covered by an assurance. The provision of the FWA will reduce the burden of regulatory compliance while strengthening the research community's ability to focus on the protection of human subjects, the Office of Human Research Protections said.

References

1. OMB Approval of the Federalwide Assurance (FWA), IRB/IEC Registration Form, and Related Documents, Office for Human Research Protections press release, 10 February 2005, http://www.hhs.gov/ohrp/news/

Latest Headlines
See All
UsernamePublicRestriction

Register

PS110513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel